Patent details

Basic Information

Publication number:

EP2269622

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP101629897

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CpG oligonucleotides used for enhancing steroid activity in a steroid dependent patient

French Title of Invention:

Olignucleotides à CpG pour l'augmentation de l'effet de stéroïdes chez un patient stéroïdes dépendant

German Title of Invention:

CpG Oligonukleotide zur Verstärkung der Steroidaktivität in steroidabhängende Patienten

SPC Number:

Dates

Filing date:

29/06/2006

Grant date:

25/12/2013

EP Publication Date:

25/12/2013

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/01/2011

EP B1 Publication Date:

25/12/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/06/2022

Expiration date:

29/06/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/06/2006

 

 

Name:

Index Pharmaceuticals AB

Address:

Scheeles väg 2, 171 77 Stockholm, Sweden (SE)

Agent

Name:

VALIPAT

From:

18/02/2014

Address:

Uitbreidingstraat 72-5, 2600, Antwerp, Belgium (BE)

To:

Inventor

1

Name:

Zargari Arezou

Address:

Sweden (SE)

2

Name:

Löfberg Robert

Address:

Sweden (SE)

3

Name:

von Stein Oliver

Address:

Sweden (SE)

Priority

Priority Number:

696173 P

Priority Date:

01/07/2005

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/00;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

28/06/2021

Last Annual Fee Paid Number:

16

Last Annual Fee Paid Amount:

230 Euro

Payer:

IPAN GMBH

Filing date	Document type	Number of pages